British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the U.S. by 2030, the company announced on Monday. The investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the U.S., AstraZeneca said. The "cornerstone" of the investment is a proposed new multibillion-dollar manufacturing facility in Virginia that will produce drug substances for the company's weight management portfolio that includes oral GLP-1 medications. AstraZeneca said the ...